Navigation Links
Cornerstone Therapeutics to Host Third Quarter 2010 Conference Call
Date:10/28/2010

related pharmaceutical products, or late-stage product candidates; implement life cycle management strategies to maximize the potential value and competitive position of the Company's currently marketed products, newly acquired products and product candidates that are currently in development; grow product revenue through the Company's specialty sales forces; and maintain and strengthen the intellectual property position of the Company's currently marketed products, newly acquired products and product candidates.

Safe Harbor Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained herein, other than statements of historical fact, including statements regarding the progress and timing of our product development programs and related trials, our strategy and our future operations and opportunities, constitute forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the results of preclinical studies and clinical trials with respect to our products under development, our ability to satisfy FDA and other regulatory requirements and the other factors described in Item 1A (Risk Factors) of our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the SEC) on March 4, 2010 and in our subsequent filings with the SEC. In addition, the statements in this press release reflect our expectations and beliefs as of the date of this release, should not be relied upon as representing our views as of any other date and do not reflect the potential impact of any acquisitions, mergers, dispositions, business development transactions, joint ventures or investments that we may make or enter into. We anticipate that subsequent events and developments will cause our expectations and beliefs to change. However, while we
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cornerstone Therapeutics Announces Development of Generic for Tussionex®
2. Cornerstone Therapeutics Licenses Alpha-7 Technology to Targacept
3. Cornerstone Therapeutics Announces Collaboration with The Cough Company
4. Cornerstone Therapeutics to Host Second Quarter 2010 Conference Call
5. Cornerstone Therapeutics Announces Management Change
6. Cornerstone Therapeutics To Present at Deutsche Banks 35th Annual Healthcare Conference
7. Cornerstone Therapeutics to Host First Quarter 2010 Conference Call
8. Cornerstone Therapeutics to Present at the 30th Annual Cowen & Company Health Care Conference
9. Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010
10. Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
11. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Cali ., Aug. 22, 2014  Research presented at ... a therapy being developed by Hera Therapeutics Inc. combats three ... percent of all cervical cancer. When tested in ... HPV-16, HPV-18 and HPV-11 cells, according to Louise T. ... presented the findings at the Seattle ...
(Date:8/22/2014)... - SQI Diagnostics Inc. (TSX-V: SQD), a life ... and products for advanced microarray diagnostics, today announced ... Agreement to contract with a UK-based company to ... initial phase of this agreement, SQI will be ... one of the customer,s assays, operational on SQI,s ...
(Date:8/21/2014)... Nektar Therapeutics (NASDAQ: NKTR ... results from its Phase 3 pivotal clinical trial ... factor VIII (rFVIII) treatment for hemophilia A based ... primary endpoint in reducing annualized bleed rates (ABR) ... arm. Top-line results from the prospective, ...
Breaking Medicine Technology:Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5
... Inc. (NYSE: HSP ), a leading global specialty ... will present at the Morgan Stanley Global Healthcare Conference on ... presentation is scheduled to begin at 8:35 a.m. Eastern time ... all interested parties through a live audiocast accessible via the ...
... Wright Therapy Products, Inc. announced today that ... Executive Officer of the company.  The company, based ... devices targeted for the treatment of lymphedema, venous ... Wright Therapy after holding senior financial and sales ...
Cached Medicine Technology:Industry Leaders Hinson and Friel Join Wright Therapy Products 2
(Date:8/23/2014)... 2014 Dealing with a drug or alcohol ... the addict is a child. Adolescent addiction has been an ... time, but a new helpline is now providing a valuable ... to find a real addiction recovery center. , The Troubled ... impact in the community. By calling (404) 975-2762, parents and ...
(Date:8/22/2014)... (PRWEB) August 23, 2014 Search ... on the first page of search engines and ... SEO Hosting has recently compared many Linux hosting ... and Bluehost are the most recommended Linux hosting ... Australia and Europe to buy high quality Linux ...
(Date:8/22/2014)... Today, Zane Benefits, the #1 Online Health ... Plans. , According to Zane Benefits, employers are adopting ... the cost of healthcare without reducing coverage for employees. ... can be confusing. , The new guide contains a ... types of ABHPs. It also explains the similarities, ...
(Date:8/22/2014)... 23, 2014 This report studies ... Liquid Handling Systems), Consumables (Tubes), Kits (Isolation, Purification), ... Diagnostics) - Global Forecast to 2018" This market ... is poised to grow at a CAGR of ... million by 2018. , Browse 98 market data ...
(Date:8/22/2014)... Recently, iFitDress.com, a well-known wedding dress manufacturer and ... wedding gowns . In addition to this, the company’s ... are provided with low shipping fees. , He ... new wedding gowns. In our online store, there are ... choose from. What’s more, all of them are extremely ...
Breaking Medicine News(10 mins):Health News:Atlanta’s New Troubled Teen Helpline Is Making a Difference in the Community 2Health News:Top10BestSEOHosting.com Announces Best Cheap Hosting Suppliers Of This Summer 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Discounted Wedding Gowns For Sale At Leading Online Shop iFitDress.com 2
... harbor profound misperceptions about the effects ... designed to help them quit, PITTSBURGH, Nov. 13 ... dangers of smoking over the past 40 years, a ... GlaxoSmithKline,Consumer Healthcare, an industry leader in smoking cessation, indicates,major ...
... Disease & Kennel Cough: Serious, But Avoidable; ... Reputable Pet Sitter, BERKELEY, Calif., Nov. 13 With ... reports regarding the highly,contagious and potentially deadly strains of canine ... cough virus -- have many dog,owners worried. So, what,s a ...
... is the only way,to describe the unsolicited testimonial received this month by ... Because of your service we were there within about ... is already home as of yesterday evening. Your service ... never work for her because when she has an ...
... Inc., a subsidiary of Natural Nutrition Inc. ... made another major,breakthrough in the international market ... Panama. InterACTIVE Nutrition brand high energy protein,products ... department in Panama.,This is a significant achievement, ...
... Today; ... in the United States, LYON, France, November 13 ... it has,signed an exclusive global collaboration agreement with Acambis plc, ... help fight against,this serious, life-altering and potentially fatal disease. Scientists,believe ...
... carbohydrates may help stunt the growth of prostate tumors, according ... The study, in mice, suggests that a reduction in insulin ... , This study showed that cutting carbohydrates may slow tumor ... urologist at Duke University Medical Center and lead researcher on ...
Cached Medicine News:Health News:Smokers Remain Unaware of the Health Effects of Smoking, New Survey Finds 2Health News:Smokers Remain Unaware of the Health Effects of Smoking, New Survey Finds 3Health News:Smokers Remain Unaware of the Health Effects of Smoking, New Survey Finds 4Health News:Smokers Remain Unaware of the Health Effects of Smoking, New Survey Finds 5Health News:Smokers Remain Unaware of the Health Effects of Smoking, New Survey Finds 6Health News:Safeguard Your Pet From Seasonal Ailments 2Health News:Safeguard Your Pet From Seasonal Ailments 3Health News:Sentry Telecare Establishes Partnering Program to Market Telephone Check-in and Personal Emergency Response Service 2Health News:Natural Nutrition Ships First InterACTIVE Nutrition Brand Products to Panama 2Health News:Sanofi Pasteur and Acambis Join Forces to Bring West Nile Vaccine to Market 2Health News:Sanofi Pasteur and Acambis Join Forces to Bring West Nile Vaccine to Market 3Health News:Sanofi Pasteur and Acambis Join Forces to Bring West Nile Vaccine to Market 4Health News:A low-carb diet may stunt prostate tumor growth 2
... The Estriol (unconjugated) enzyme immunoassay (EIA) test ... in vitro,determination of unconjugated estriol in human ... The Estriol (unconjugated) procedure is an enzyme ... competitive binding. In this procedure, estriol is ...
LH EIA Reproductive Markers 025-BC-1031 Luteinizing Hormone...
... based on the competition principle and the ... in the sample and a fixed amount ... for the,binding sites of a polyclonal Estradiol ... hours incubation the microtiterplate is,washed to stop ...
... the most important androgen secreted into the ... the Leydig cells of the testes; in ... derived from,peripheral conversion of androstenedione, ca. 25% ... the adrenal glands. The Testosterone ELISA KIT ...
Medicine Products: